Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses

Jin H. Lee, Do S. Byun, Min G. Lee, Byung K. Ryu, Min J. Kang, Kwon Seok Chae, Kil Yeon Lee, Hyo Jong Kim, Heonyong Park, Sung-Gil Chi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

hSRBC is a putative tumor suppressor located at 11p15.4, at which frequent genomic loss has been observed in several human malignancies. To explore the candidacy of hSRBC as a suppressor of gastric tumorigenesis, we analyzed the expression and mutation status of hSRBC in gastric tissues and cell lines. hSRBC transcript was expressed in all normal and benign tumor tissues examined, but undetectable or very low in 73% (11/15) cancer cell lines and 41% (46/111) primary tumors. Loss or reduction of hSRBC expression was tumor-specific and correlated with stage and grade of tumors. While allelic loss or somatic mutations of the gene were infrequent, its expression was restored in tumor cells by 5-aza-2′-deoxycytidine treatment and aberrant hypermethylation of 23 CpG sites in the promoter region showed a tight association with altered expression. Transient or stable expression of hSRBC led to a G1 cell cycle arrest and apoptosis of tumor cells, and strongly suppresses colony forming ability and xenograft tumor growth. In addition, hSRBC elevated apoptotic sensitivity of tumor cells to genotoxic agents, such as 5-FU, etoposide and ultraviolet. Interestingly, hSRBC increased the protein stability of p53 and expression of p53 target genes, such as p21Waf1, PUMA and NOXA, while hSRBC-mediated cell cycle arrest and apoptosis were abolished by blockade of p53 function. Our findings suggest that hSRBC is a novel tumor suppressor whose epigenetic inactivation contributes to the malignant progression of gastric tumors, in part, through attenuated p53 response to stresses.

Original languageEnglish
Pages (from-to)1573-1584
Number of pages12
JournalInternational Journal of Cancer
Volume122
Issue number7
DOIs
Publication statusPublished - 2008 Apr 1

Fingerprint

Epigenomics
Stomach Neoplasms
Neoplasms
Stomach
decitabine
Apoptosis
G1 Phase Cell Cycle Checkpoints
Cell Line
Mutation
Protein Stability
Loss of Heterozygosity
p53 Genes
Etoposide
Cell Cycle Checkpoints
Heterografts
Genetic Promoter Regions
Fluorouracil
Carcinogenesis

Keywords

  • Gastric cancer
  • hSRBC
  • p53
  • Promoter hypermethylation
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Cancer Research
  • Medicine(all)
  • Oncology

Cite this

Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses. / Lee, Jin H.; Byun, Do S.; Lee, Min G.; Ryu, Byung K.; Kang, Min J.; Chae, Kwon Seok; Lee, Kil Yeon; Kim, Hyo Jong; Park, Heonyong; Chi, Sung-Gil.

In: International Journal of Cancer, Vol. 122, No. 7, 01.04.2008, p. 1573-1584.

Research output: Contribution to journalArticle

Lee, Jin H. ; Byun, Do S. ; Lee, Min G. ; Ryu, Byung K. ; Kang, Min J. ; Chae, Kwon Seok ; Lee, Kil Yeon ; Kim, Hyo Jong ; Park, Heonyong ; Chi, Sung-Gil. / Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses. In: International Journal of Cancer. 2008 ; Vol. 122, No. 7. pp. 1573-1584.
@article{04a48234de79492f9af1c7cd63a2fb99,
title = "Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses",
abstract = "hSRBC is a putative tumor suppressor located at 11p15.4, at which frequent genomic loss has been observed in several human malignancies. To explore the candidacy of hSRBC as a suppressor of gastric tumorigenesis, we analyzed the expression and mutation status of hSRBC in gastric tissues and cell lines. hSRBC transcript was expressed in all normal and benign tumor tissues examined, but undetectable or very low in 73{\%} (11/15) cancer cell lines and 41{\%} (46/111) primary tumors. Loss or reduction of hSRBC expression was tumor-specific and correlated with stage and grade of tumors. While allelic loss or somatic mutations of the gene were infrequent, its expression was restored in tumor cells by 5-aza-2′-deoxycytidine treatment and aberrant hypermethylation of 23 CpG sites in the promoter region showed a tight association with altered expression. Transient or stable expression of hSRBC led to a G1 cell cycle arrest and apoptosis of tumor cells, and strongly suppresses colony forming ability and xenograft tumor growth. In addition, hSRBC elevated apoptotic sensitivity of tumor cells to genotoxic agents, such as 5-FU, etoposide and ultraviolet. Interestingly, hSRBC increased the protein stability of p53 and expression of p53 target genes, such as p21Waf1, PUMA and NOXA, while hSRBC-mediated cell cycle arrest and apoptosis were abolished by blockade of p53 function. Our findings suggest that hSRBC is a novel tumor suppressor whose epigenetic inactivation contributes to the malignant progression of gastric tumors, in part, through attenuated p53 response to stresses.",
keywords = "Gastric cancer, hSRBC, p53, Promoter hypermethylation, Tumor suppressor gene",
author = "Lee, {Jin H.} and Byun, {Do S.} and Lee, {Min G.} and Ryu, {Byung K.} and Kang, {Min J.} and Chae, {Kwon Seok} and Lee, {Kil Yeon} and Kim, {Hyo Jong} and Heonyong Park and Sung-Gil Chi",
year = "2008",
month = "4",
day = "1",
doi = "10.1002/ijc.23166",
language = "English",
volume = "122",
pages = "1573--1584",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses

AU - Lee, Jin H.

AU - Byun, Do S.

AU - Lee, Min G.

AU - Ryu, Byung K.

AU - Kang, Min J.

AU - Chae, Kwon Seok

AU - Lee, Kil Yeon

AU - Kim, Hyo Jong

AU - Park, Heonyong

AU - Chi, Sung-Gil

PY - 2008/4/1

Y1 - 2008/4/1

N2 - hSRBC is a putative tumor suppressor located at 11p15.4, at which frequent genomic loss has been observed in several human malignancies. To explore the candidacy of hSRBC as a suppressor of gastric tumorigenesis, we analyzed the expression and mutation status of hSRBC in gastric tissues and cell lines. hSRBC transcript was expressed in all normal and benign tumor tissues examined, but undetectable or very low in 73% (11/15) cancer cell lines and 41% (46/111) primary tumors. Loss or reduction of hSRBC expression was tumor-specific and correlated with stage and grade of tumors. While allelic loss or somatic mutations of the gene were infrequent, its expression was restored in tumor cells by 5-aza-2′-deoxycytidine treatment and aberrant hypermethylation of 23 CpG sites in the promoter region showed a tight association with altered expression. Transient or stable expression of hSRBC led to a G1 cell cycle arrest and apoptosis of tumor cells, and strongly suppresses colony forming ability and xenograft tumor growth. In addition, hSRBC elevated apoptotic sensitivity of tumor cells to genotoxic agents, such as 5-FU, etoposide and ultraviolet. Interestingly, hSRBC increased the protein stability of p53 and expression of p53 target genes, such as p21Waf1, PUMA and NOXA, while hSRBC-mediated cell cycle arrest and apoptosis were abolished by blockade of p53 function. Our findings suggest that hSRBC is a novel tumor suppressor whose epigenetic inactivation contributes to the malignant progression of gastric tumors, in part, through attenuated p53 response to stresses.

AB - hSRBC is a putative tumor suppressor located at 11p15.4, at which frequent genomic loss has been observed in several human malignancies. To explore the candidacy of hSRBC as a suppressor of gastric tumorigenesis, we analyzed the expression and mutation status of hSRBC in gastric tissues and cell lines. hSRBC transcript was expressed in all normal and benign tumor tissues examined, but undetectable or very low in 73% (11/15) cancer cell lines and 41% (46/111) primary tumors. Loss or reduction of hSRBC expression was tumor-specific and correlated with stage and grade of tumors. While allelic loss or somatic mutations of the gene were infrequent, its expression was restored in tumor cells by 5-aza-2′-deoxycytidine treatment and aberrant hypermethylation of 23 CpG sites in the promoter region showed a tight association with altered expression. Transient or stable expression of hSRBC led to a G1 cell cycle arrest and apoptosis of tumor cells, and strongly suppresses colony forming ability and xenograft tumor growth. In addition, hSRBC elevated apoptotic sensitivity of tumor cells to genotoxic agents, such as 5-FU, etoposide and ultraviolet. Interestingly, hSRBC increased the protein stability of p53 and expression of p53 target genes, such as p21Waf1, PUMA and NOXA, while hSRBC-mediated cell cycle arrest and apoptosis were abolished by blockade of p53 function. Our findings suggest that hSRBC is a novel tumor suppressor whose epigenetic inactivation contributes to the malignant progression of gastric tumors, in part, through attenuated p53 response to stresses.

KW - Gastric cancer

KW - hSRBC

KW - p53

KW - Promoter hypermethylation

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=39649094115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649094115&partnerID=8YFLogxK

U2 - 10.1002/ijc.23166

DO - 10.1002/ijc.23166

M3 - Article

VL - 122

SP - 1573

EP - 1584

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 7

ER -